Streetinsider

Published September 14, 2026

Definium's LSD -based pill meets Phase 3 goals in anxiety trial - StreetInsider

Read the full story at Streetinsider

Definium's LSD -based pill meets Phase 3 goals in anxiety trial. September 14, 2026 7:01 AM. Definium Therapeutics (Nasdaq: DFTX) announced positive.